The thioredoxin redox system has been suggested recently as a therapeutic target for cancer therapy [17,18], based on the observation that thioredoxin is overexpressed in many aggressive tumors and that siRNA-mediated knockdown of TXNRD1 decreased tumor progression and metastasis in mice [19]. Here, TXN is linked to cancer.